AM
Therapeutic Areas
Viatris Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Semglee (insulin glargine biosimilar) | Diabetes | Approved |
| Mvasi (bevacizumab biosimilar) | Oncology | Approved |
| Ogivri (trastuzumab biosimilar) | Breast Cancer | Approved |
| EpiPen | Anaphylaxis | Approved |
| Lipitor | Cardiovascular Disease | Approved |
| Lyrica | Neuropathic Pain | Approved |
| Norvasc | Hypertension | Approved |
| Viagra | Erectile Dysfunction | Approved |
Leadership Team at Viatris
SA
Scott A. Smith
Chief Executive Officer
SN
Sanjeev Narula
Chief Financial Officer
RM
Rajiv Malik
President
SR
Sarah Romano Christy
Chief Legal Officer
MP
Mary Pat McCarthy
Chief Human Resources Officer
CV
Clarence Verhoeven
Chief Information Officer
EC
Eric Cortigiani
President, Greater China